Duodenal Exclusion for the Treatment of T2DM
NCT00456352 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2014-08-22
Summary
Evaluation of duodenal exclusion procedure for the treatment of T2DM
Conditions
Interventions
- PROCEDURE
-
duodenal exclusion
Sponsors & Collaborators
-
Medtronic - MITG
lead INDUSTRY
Principal Investigators
-
Noreen A Gannon · Medtronic - MITG
-
Ricardo Cohen, MD · Hospital São Camilo
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2009-04-30
- Completion
- 2010-10-31
Countries
- Brazil
Study Locations
More Related Trials
-
Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality
NCT04453605 ·Status: COMPLETED
-
Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort
NCT04949152 ·Status: RECRUITING
-
Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes
NCT06125119 ·Status: RECRUITING
-
THE Effect of Tight Glycemic Control on Microvascular Complications in Type 2 Diabetes Mellitus
NCT07049601 ·Status: COMPLETED ·Phase: NA
-
Diabetes Complication Control in Community Clinics (D4C) Trial
NCT02835287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus
NCT05631561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intensive Discharge Intervention in Diabetes
NCT02122926 ·Status: COMPLETED ·Phase: NA
-
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh
NCT01877200 ·Status: COMPLETED
-
Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old
NCT00843232 ·Status: COMPLETED
-
The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
NCT00850798 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)
NCT01285076 ·Status: COMPLETED
-
Metformin in the Diastolic Dysfunction of Metabolic Syndrome
NCT02017561 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Type 2 Diabetes Mellitus on the Success of Adult Pulpotomy
NCT07332026 ·Status: COMPLETED ·Phase: NA
-
Mesenchymal Stem Cells to Treat Type 2 Diabetes
NCT02302599 ·Status: COMPLETED ·Phase: PHASE2
-
Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
NCT02166372 ·Status: RECRUITING
-
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
NCT04522882 ·Status: COMPLETED ·Phase: NA
-
DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients
NCT03033433 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients
NCT01943214 ·Status: UNKNOWN
-
Plaque Composition in T2DM With and Without Microvascular Complications
NCT06439719 ·Status: NOT_YET_RECRUITING
-
Myocardial Perfusion in Type 2 Diabetes
NCT01043965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Glycaemia and Cardiac Function in Patients With COVID-19
NCT04410718 ·Status: COMPLETED
-
The DIAMOND® for the Treatment of Type 2 Diabetes
NCT02079376 ·Status: UNKNOWN ·Phase: NA
-
Chronic Passive Heating in Individuals With T2DM
NCT04858321 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
NCT01283113 ·Status: COMPLETED
-
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
NCT00814190 ·Status: COMPLETED ·Phase: NA